EyeWorld Korea June 2019 Issue

EWAP JUNE 2019 33 SECONDARY FEATURE ࣻ֙р ੉۞ೠ ജ੗ٜ੉ ੢ӝр ࢿҕ੸ Ѿҗܳ ࠁ ੉ ח Ѫਸ ࠁ ওҊ ੉ ח 1,1( ജ੗ীࢲ ઁо о੢ ࢶഐೞ ߨߑ ח ੑ פ ׮ u ۄ Ҋ "ZZMB ߅ ࢎ ח ݈೮׮ ੉۞ೠ ࣻࣿਸ Ѿ೤ೞ ח ޙ ઁীࢲ ח ҃೷੉ ઺ਃ೤ פ ׮ #FSEBIM ߅ ࢎ ח ղೖ ੹கп݄ ੉धࣿҗ ֣ղ੢ ࣻࣿਸ Ѿ೤ೡ ࣻ ੓ਵա ઱੄ೡ ੼੉ ੓׮Ҋ ࢤпೠ׮ t%.&,৬ ز दী ݆਷ J4UFOUT<(MBVLPT 4BO $MFNFOUF $BMJGPSOJB>ܳ द೯ೞ৓ण פ ׮ Ӓ۞ա ৉ ܨ ৬ ୹ആ੄ ਤ೷੉ ੓׮ ח Ѫਸ ঌইঠ ೤ פ ׮ Ӓۡ ҃਋ %.&, ݒ ח ਋ য۰ਕ૘ פ ׮ u ۄ Ҋ Ӓ ח ࢸ ݺ ೮׮ t ࠁ ׮ ؊ ࠁ ࣻ੸ੋ ߨߑ ਷ %4&, ੑ פ ׮ %4&,ܳ ࢿҕ੸ਵ ۽ द೯ೡ ࣻ ੓׮ ח ਋ܻ੄ ؘ੉ఠܳ ઁदೞ৓ण פ ׮ ੉۞ೠ Ѿ೤੸ ੽Ӕ ߨ ীࢲ о੢ જ਷ Ѫ਷ ࢻਬ઱ ਋ഥझబ౟о ੓ਸ ҃਋ झప ۽ ੉٘ ਬ ߊ উ঑ ә࢚थী ؀ೠ ਋۰о ੸׮ ח Ѫੑ פ ׮ ੹ ߑ ୹ആਸ ਬ ߊ ೡ о מ ࢿ੉ о੢ ੸਷ ߨߑ ਸ ࢎਊೡ Ѫਸ ӂ೤ פ ׮ ݅ড ߔ ղ੢ ࣻࣿҗ ߽೯ೡ ҃਋ ߔ ղ੢ਸ ઁѢೞӝ ੹ী ֣ղ੢ ࣻࣿਸ ݢ ੷ ೞৈ ୹ആਸ فݽ ࣁୋೞҊ ղೖࣁನ੉धਸ ೡ ତী ח ୹ആ੉ ݥ ୶ ۾ب ೞ ח ߑ धਸ ӂ೤ פ ׮ u Ӓо ҕ ز োҳ੗৓؍ ੉ োҳীࢲ ח ಺झ ղೖࣁನ ੉࢚ૐ ѐ ߑ п֣ղ੢ ߂ ਬ੄ೠ ߔ ղ੢੉ ੓ ݺ ח ੄ ജ੗ীࢲ ߔ ղ੢ ࣻࣿী ؊ࠛয %.&, %4&,৬ ࢻਬ઱ ޷ࣁ ਋ഥ झబ౟ ࢗੑࣿਸ Ѿ೤ೞৈ द೯೧઱঻׮ Ӓ Ѿҗ द۱੉ ਵ ۽ ѐࢶ غ ঻ਵ ݴ োҳ ؀࢚੗ ઺ ݺ ীࢲ ୭ࣗ ف ઴ ѐࢶ غ ঻ਵ ݴ ড ޛ ࢎਊ੉ ѐীࢲ ѐ ۽ хࣗ Q ӒܻҊ ಣӐ *01о NN)H хࣗ೮਺੉ ഛੋ غ ঻׮ ೠ উҳীࢲ݅ ੉धಞ Ү୓о ೙ਃ೮ਵ ژ ݴ ׮ܲ ೠ ׀ীࢲ * ח 01 ઑ੺ਸ ਤ೧ ֣ղ੢ ࠳ߖ ࣻࣿ੉ ೙ਃ೮׮ пп੄ ੄ࢎٜ਷ ݒ ਋ ࠂ ੟ೠ ࣻࣿ੸ ࢚ടী ؀೧ пп੄ ੽Ӕ ߨ ਸ ыҊ ੓ਸ Ѫ੉׮ %S "ZZBMB ח ౠ൤ ֣ղ੢ ࣻࣿ੉ ࢻਬ઱੺ઁࣿ ղ૑ %%( ח ੋ ҃਋ ੉धಞਸ ڸ ਋ӝ ਤ೧ ੹ ߑ ী ҕӝ ߑ ਎ਸ ਬ૑ೞ ח Ѫ੉ য۵ӝ ޙٸ ী %4&,৬ ֣ղ੢ ࣻࣿਸ ߽೯ೞ ח Ѫਸ ӂೞ૑ ঋ ח ׮ ݶ߈ J4UFOU৬ ,BIPPL %VBM #MBEF /FX 8PSME .FEJDBM 3BODIP $VDBNPOHB $BMJGPSOJB җ э੉ $BOBMী ӝ ߈ ೠ ٜࣻࣿ੉ %4&, ৬ Ѿ೤ חغ Ѫ਷ ੹ ߑ ਵ ۽ ആঘਸ ৉ ܨ दெ %4&, ࣻࣿਸ য۵ѱ ೡ ࣻ ب ੓਺ী ب ࠛҳೞҊ ߽೯ೡ ࣻ ੓׮Ҋ ࢤпೠ׮ %S "ZZBMB ח ন૕੄ ੐࢚ಣоܳ ా೧ ജ੗ܳ ୶੸ҙ଴ೞ ݴ োࣘ੸ੋ ղೖ ࣁನ ࣻ Ѩࢎܳ ӂ੢ೠ׮ פݽ ఠ݂ೞ ߨߑ ח t਋ܻ ח ࣻࣿਸ द೯ೠ ֣ղ੢ ജ੗ٜਸ ੐࢚੸ ਭউ੸ਵ ۽ ҙ଴ೞҊ ੿ӝ੸ੋ ֣ղ੢ ୶੸ ҙ଴ਸ पद೤ פ ׮ u ۄ Ҋ %S #FSEBIM ੉ ݈೮׮ t਋ܻ ח р೵੸ਵ ۽ п݄ ف ԋஏ੿ਸ द೯ೞҊ ݅ড द۱੉ ୭੸੉ ই ݶۄפ ղೖࣁನ ࣻܳ ஏ੿೤ פ ׮ Ӓ۞ա п݄ ղೖࣁನܳ Ѩࢎೞ ח ঌҊ્ܻ੸ ੽Ӕ੉ ۽ٮ ੓׮Ҋ ࢤпೞ૑ ח ঋण פ ׮ п݄ ղೖܳ ࠁ ഐೡ ࣻ ੓ ח ୭ࢶ਷ જ਷ ࣻࣿ੸ ӝࣿ ۽ ࣻࣿਸ ೞ ݴ ੷উ঑ ࢚కܳ ೖೞҊ ੹ ߑ ղ੄ ੢஖о п݄ ղೖ ۽ ࠗఠ ݣ ܻ ڄ যઉ ੓ ۾ب ೞ ח Ѫੑ פ ׮ u ۄ Ҋ Ӓ ח ࢸ ݺ ೞ৓׮ EWAP References 1. Janson BJ, et al. Glaucoma-associated corneal endothelial cell damage: a review. Surv Ophthalmol. 2017;63:500–506. 2. Ayyala RS. Penetrating keratoplasty and glaucoma. Surv Ophthalmol. 2000;45:91–105. 3. Williamson BK, et al. The effects of glaucoma drainage devices on oxygen tension, glycolytic metabolites, and “iÌ>Lœœ“ˆVà «Àœwi œv >µÕiœÕÅՓœÀ in the rabbit. Transl Vis Sci Technol. 2018;7:14. 4. Ayyala RS, et al. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. Ophthalmol. 1998;105:1550–6. 5. Yelenskiy A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27:920–925. 6. Stunkel M, et al. Outcomes of partial-thickness corneal transplantation combined with trabecular bypass stent implantation and cataract surgery. Presented at the 2017 ASCRS•ASOA Symposium & Congress. Ӓܿ .45 HSBTQFSܳ ੉ਊ೧ झబ౟ܳ ઁѢೠ׮ Ӓܿ ੹ ߑ п҃ Ѩࢎীࢲ झబ౟о ੹ ߑ пী ਤ஖ೞҊ ੓ਵ ݴ п݄җ ڄ যઉ ੓਺ਸ ࠅ ࣻ ੓׮ ୹୊ ੹୓ +PIO #FSEBIM .%